These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
147 related items for PubMed ID: 17651259
21. Angiographic changes in iris and iridocorneal angle neovascularization after intravitreal bevacizumab injection. Ishibashi S, Tawara A, Sohma R, Kubota T, Toh N. Arch Ophthalmol; 2010 Dec; 128(12):1539-45. PubMed ID: 21149776 [Abstract] [Full Text] [Related]
23. Intraocular avastin (bevacizumab) for neovascularisation of the iris and neovascular glaucoma. Cheng JY, Wong DW, Ang CL. Ann Acad Med Singap; 2008 Jan; 37(1):72-4. PubMed ID: 18265902 [Abstract] [Full Text] [Related]
24. Bevacizumab in conjunction with panretinal photocoagulation for neovascular glaucoma. Wasik A, Song HF, Grimes A, Engelke C, Thomas A. Optometry; 2009 May; 80(5):243-8. PubMed ID: 19410229 [Abstract] [Full Text] [Related]
25. [The treatment of the rubeosis of the iris and the neovascular glaucoma in proliferative diabetic retinopathy by means of anti-VEGF]. Cernák M, Markovic O, Cernák A. Cesk Slov Oftalmol; 2008 Nov; 64(6):234-6. PubMed ID: 19110964 [Abstract] [Full Text] [Related]
30. Clinical factors related to recurrence of anterior segment neovascularization after treatment including intravitreal bevacizumab. Saito Y, Higashide T, Takeda H, Murotani E, Ohkubo S, Sugiyama K. Am J Ophthalmol; 2010 Jun 01; 149(6):964-972.e1. PubMed ID: 20381786 [Abstract] [Full Text] [Related]
31. Intravitreal bevacizumab for iris neovascularization following proton beam irradiation for choroidal melanoma. Yeung SN, Paton KE, Waite C, Maberley DA. Can J Ophthalmol; 2010 Jun 01; 45(3):269-73. PubMed ID: 20379286 [Abstract] [Full Text] [Related]
32. Role of intravitreal bevacizumab in neovascular glaucoma. Gheith ME, Siam GA, de Barros DS, Garg SJ, Moster MR. J Ocul Pharmacol Ther; 2007 Oct 01; 23(5):487-91. PubMed ID: 17900231 [Abstract] [Full Text] [Related]
36. Regression of neovascular posterior capsule vessels by intravitreal bevacizumab. Eren E, Küçükerdönmez C, Yilmaz G, Akova YA. J Cataract Refract Surg; 2007 Jun 01; 33(6):1113-5. PubMed ID: 17531712 [Abstract] [Full Text] [Related]
37. Combination intravitreal bevacizumab/panretinal photocoagulation versus panretinal photocoagulation alone in the treatment of neovascular glaucoma. Ehlers JP, Spirn MJ, Lam A, Sivalingam A, Samuel MA, Tasman W. Retina; 2008 May 01; 28(5):696-702. PubMed ID: 18463512 [Abstract] [Full Text] [Related]
38. The effect of different doses of intracameral bevacizumab on surgical outcomes of trabeculectomy for neovascular glaucoma. Georgalas I, Koutsandrea C, Papaconstantinou D, Petrou P, Ladas I. Eur J Ophthalmol; 2010 May 01; 20(1):251; author reply 252. PubMed ID: 20047184 [No Abstract] [Full Text] [Related]